Skip to content

Efficacy of antimalaria drug for the treatment of malaria

Therapeutic efficacy and safety of Artemether-Lumefantrine combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria at Teda Health Center, Northwest Ethiopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202309773069812
Enrollment
88
Registered
2023-09-01
Start date
2022-09-10
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

no intervention

Sponsors

University of Gondar
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Age 6 months–70 years • No history of malaria treatment within the last 28 days • Permanent resident within 5 km radius from the HC • Plasmodium falciparum infection confirmed by microscopy • Parasitaemia level of 1,000/µl-100,000/µl asexual forms • Presence of axillary temperature = 37.5 °C or history of fever during the past 24hs • Ability to swallow oral medication • Ability to comply to the study protocol

Exclusion criteria

Exclusion criteria: • Presence of complication or danger signs of severe malaria • Presence of severe malnutrition (body mass index (BMI) <18.5 kg/m2 or z-score <3) • Presence of known diseases other than malaria (typhoid fever, typhus, hepatitis, HIV/AIDS, pneumonia and tuberculosis) • Regular medications that may interfere with AL pharmacokinetics (antiretroviral, ketoconazole and rifampicin) • History of hypersensitivity reactions to AL • Pregnancy or lactating women • Vomited twice during drug administration

Design outcomes

Primary

MeasureTime frame
adequate clinical and parasitological response

Secondary

MeasureTime frame
Asexual parasitaemia and fever clearance

Countries

Ethiopia

Contacts

Public ContactAlemayehu Nigussie

Researcher

alex.nigussie@gmail.com+251928701023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026